The Department of Energy’s Office of Nuclear Energy awarded more than $19 million to five U.S. companies—Alpha Nur, Curio Solutions, Flibe Energy, Oklo, and Shine Technologies—to research and develop recycling technologies for spent nuclear fuel (SNF).

According to DOE-NE, the projects will support President Trump’s goal of curtailing U.S. reliance on foreign sources of enriched uranium while reducing the volume of SNF stored across the country. Projects are to last up to three years and will require a minimum 20 percent cost share from each award recipient.

The new Great Lakes Fusion Energy Alliance wants to build a fusion energy engineering consortium in the Great Lakes region to expand the Midwestern momentum behind fusion energy development and commercialization. The ultimate goal is to build fusion energy power plants in the region, but first the nascent organization is looking to invite other stakeholders into its alliance of universities, fusion companies, and supply chain and government partners. Together, they plan to “accelerate commercialization, expand the workforce, grow the supply chain, and make fusion more economically viable and sustainable as a global center of excellence.”

Next Tuesday, March 5, the American Nuclear Society’s Nuclear Nonproliferation Policy Division will host a members-only event on the development of a U.S.-based used nuclear fuel recycling pilot facility. Ross Radel, chief technology officer of SHINE Technologies, will speak about the new initiative.

The webinar will take place from 4:00 p.m. to 5:00 p.m. (EST). Register now.

The Nuclear Regulatory Commission has issued its final safety evaluation report (SER) related to the operating license application for SHINE Technologies' large-scale medical isotope production facility, known as The Chrysalis, in Janesville, Wis. The SER documents the results of NRC staff’s technical and safety review of SHINE’s application. SHINE announced the NRC’s decision on February 27.

A record of decision concerning the proposed issuance of the operating license will be published by the NRC at a future date.

The Nuclear Regulatory Commission has issued the final supplemental environmental impact statement (EIS) for SHINE Technology’s application for a license to operate a medical isotope production facility in Janesville, Wis.

SHINE Europe, a subsidiary of Wisconsin-based SHINE Technologies, will work with the Netherlands’ University Medical Center Groningen (UMCG) and Delft University of Technology (TU Delft) to produce a variety of terbium isotopes for use in nuclear medicine under a grant proposal approved by the Dutch government on October 17.

The Department of Energy’s National Nuclear Security Administration and Office of Environmental Management (EM) have signed the first contracts under the DOE’s Uranium Lease and Take-back Program with SHINE Technologies. The DOE called it a milestone in its effort to increase domestic production of molybdenum-99 (Mo-99), a medical isotope used in more than 40,000 medical procedures in the United States each day, without the use of high-enriched uranium.

SHINE Technologies, of Janesville, Wis., is one of the NNSA’s cooperative agreement partners. In October 2021, the NNSA awarded SHINE $35 million to support its efforts to produce Mo-99 commercially by the end of 2023.

Click here for more information on the NNSA efforts to establish a reliable supply of Mo‑99 without the use of HEU.